Immune response to Plasmodium falciparum liver stage antigen-1: geographical variations within Central Africa and their relationship with protection from clinical malaria.
about
Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.Changes in antigen-specific cytokine and chemokine responses to Plasmodium falciparum antigens in a highland area of Kenya after a prolonged absence of malaria exposure.A multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens.Analysis of human antibodies to erythrocyte binding antigen 175 peptide 4 of Plasmodium falciparum.Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana.Antibodies to the Plasmodium falciparum antigens circumsporozoite protein, thrombospondin-related adhesive protein, and liver-stage antigen 1 vary by ages of subjects and by season in a highland area of KenyaCachexia in malaria and heart failure: therapeutic considerations in clinical practice.Assessment of exposure to Plasmodium falciparum transmission in a low endemicity area by using multiplex fluorescent microsphere-based serological assaysComparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates.Analysis of antibody profiles in symptomatic malaria in three sentinel sites of Ivory Coast by using multiplex, fluorescent, magnetic, bead-based serological assay (MAGPIX™).Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission.Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children.Interferon-γ--central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria.
P2860
Q33587443-8DF2C2BA-E035-4DB3-8165-B4663B24EAFAQ34298486-71F95B83-B0BC-4F4D-A051-4589A96CEFB9Q34351117-59855222-F84B-4DCF-8560-3E6430289B67Q34537136-0071F21A-2ED3-4FE2-A045-558B1868EE75Q35003931-B6BBF411-B9BF-4923-8BA0-113975ECA61BQ35165581-6763DA10-2EAD-4383-B3C1-063A1886841DQ35520657-43A76AC4-2B6A-4BEC-946C-2FC384AA409EQ35570377-D43F1D47-42C3-4D8D-B06B-2A0FD742C8EEQ35813430-32271410-5DE5-4ACB-9799-9EAF2271DA5EQ36393772-0811FDB3-ACB7-4832-8C69-835B15A69FF3Q36974401-242DBB2A-380D-4F74-9DF5-5245CDEF0B75Q37023939-05ECC51F-3AA9-478B-9B3D-FC5FFAF3EFC4Q37770828-357253FC-B6DC-4AC3-A423-522EE0F7D1A1
P2860
Immune response to Plasmodium falciparum liver stage antigen-1: geographical variations within Central Africa and their relationship with protection from clinical malaria.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Immune response to Plasmodium ...... tection from clinical malaria.
@en
Immune response to Plasmodium ...... tection from clinical malaria.
@nl
type
label
Immune response to Plasmodium ...... tection from clinical malaria.
@en
Immune response to Plasmodium ...... tection from clinical malaria.
@nl
prefLabel
Immune response to Plasmodium ...... tection from clinical malaria.
@en
Immune response to Plasmodium ...... tection from clinical malaria.
@nl
P2093
P2860
P50
P1476
Immune response to Plasmodium ...... otection from clinical malaria
@en
P2093
P2860
P304
P356
10.1016/S0035-9203(00)90086-5
P577
2000-09-01T00:00:00Z